A new study commissioned by Food Supplements Europe has found that savings of €5.3 billion (US$5.77 billion) a yeamolybdenum citrater could be generated through the daily consumption of 1.7g of phytosterols by the millions of adults aged 55 and over in the EU with severe hypercholesterolemia.###Hypercholesterolemia is the presence of high levels of low-density lipoprotein (LDL) cholesterol in the blood, which is strongly associated with a higher risk of cardiovascular disease (CVD).###Across the Emagnesium citrateU, 31.1 million over-55seffervescent magnesium citrate are living with severe hypercholesterolemia. ###They have an estimated 24.3% risk of experiencing a CVD-attributed hospital event as a result.###Meanwhile, Frost & Sullivan calculated the economic burden of addressing cases of CVD linked to hypercholesterolemia among this population.###It discovered it is set to cost EU healthcare systems and providers €1.328 trillion between 2016 and 2020 – €266 billion a year, and equivalent to €34,637 per event.###Phytosterols are proven toferretti ferrous gluconate reduce levels of LDL cholesterol. ###Following an analysis of the available science, Frost & Sullivan concluded that consumption of 1.7g of phytcal citrateosterols a day by EU adults aged 55+ with severe hypercholesterolemia would cut their risk of experiencing a CVD-attributed hospital event associated with their condition by 2.3% basis points.###In turn, this would result in cost savings of €26.5 billion over five years, or €5.3 billion a year.